参考文献/References:
[1]Zhao H, Lv Y, Li L, et al. Genetic Studies on Polycystic Ovary Syndrome [J]. Best Practice & Research Clinical Obstetrics & Gynaecology, 2016,37(11):56-65.
[2]Shi Y, Zhao H, Shi Y, et al. Genome-wide association study identifies eight new risk loci for polycystic ovary syndrome [J]. Nat Genet., 2012, 44(9): 1020-1025.
[3]Insenser M, Escobar-Morreale H F. Application of proteomics to the study of polycystic ovary syndrome [J]. Journal of Endocrinological Investigation, 2011, 34(11):869-875.
[4]Skov V, Glintborg D, Knudsen S, et al.Pioglitazone enhances mitochondrial biogenesis and ribosomal protein biosynthesis in skeletal muscle in polycystic ovary syndrome [J].PLoS One. 2008,3(6):1142.
[5]Wood JR, Nelson-Degrave VL, Jansen E, et al. Valproate-induced alterations in human theca cell gene expression: clues to the association between valproate use and metabolic side effects [J]. Physiol Genomics, 2005, 20(3):233-343.
[6]Cortón M, Botella-Carretero JI, Benguría A, et al.Differential gene expression profile in omental adipose tissue in women with polycystic ovary syndrome [J]. J Clin Endocrinol Metab., 2007, 92(1):328-337.
[7]李威, 丛晶, 匡红影,等. 卵巢颗粒细胞基因表达异常与PCOS高雄激素血症 [J]. 中华内分泌外科杂志, 2012,6(4):270-271.
[8]Jr O F, Matarese G, Di B S S, et al. Exon 6 and 2 peroxisome proliferator-activated receptor-gamma polymorphisms in polycystic ovary syndrome [J]. Journal of Clinical Endocrinology & Metabolism, 2003, 88(12):5887-5892.
[9]夏燕, 王惠仔, 郑建淮. 慢性炎症因子在多囊卵巢综合征中的作用机制 [J]. 中国实验动物学报, 2010, 18(5):414-416.
[10]陈慧玲,郑连文,路英丽,等. PCOS中低度慢性炎症相关因子的研究进展 [J]. 中国妇幼保健,2016,31(9):2007-2011.